Our team is here to help you respond quickly and safely
Our design caters to a range of medical professionals, such as med spas, weight loss clinics, functional medicine providers, and wellness clinics, who currently offer or plan to add Semaglutide to their practice
Cardiovascular safety data from published trials showed reductions in systolic blood pressure (ranging from 4.3 to 7.9 mmHg depending on dose) and diastolic blood pressure (2.3 to 4.6 mmHg reductions)
Methods Using a subset of Truveta Data, we identified patients who had a prescription for a GLP-1 RA between June 2021 and December 2024
These outlined the mode and frequency of administration, as well as the changes in HbA 1c , body weight, and risk of nausea, expected with oral semaglutide 7 and 14 mg, liraglutide 0.9 mg, and dulaglutide 0.75 mg, based on the results from the PIONEER 9 and 10 trials